<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
  <head>
    <meta content="text/html;charset=utf-8" http-equiv="Content-Type"/>
    <title>CUPRIOR Filmtabl 150 mg 72 Stk (Bundle) - CH EPL (R5) v1.0.0-ballot</title>

    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <meta name="author" content="http://hl7.org/fhir"/>

    <link href="fhir.css" rel="stylesheet"/>

    <!-- Bootstrap core CSS -->
    <link href="assets/css/bootstrap-fhir.css" rel="stylesheet"/>

    <!-- Project extras -->
    <link href="assets/css/project.css" rel="stylesheet"/>
    <link href="assets/css/pygments-manni.css" rel="stylesheet"/>
    <link href="assets/css/jquery-ui.css" rel="stylesheet"/>
  	<link href="assets/css/prism.css" rel="stylesheet" />
  	<link href="assets/css/cqf.css" rel="stylesheet" />
    <!-- Placeholder for child template CSS declarations -->
    <link href="assets/css/hl7.css" rel="stylesheet"/>
    <link href="assets/css/fhir.css" rel="stylesheet"/>

    <style>
    

    

    

    </style>
 

    <script type="text/javascript" src="fhir-table-scripts.js"> </script>

    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
    <script src="assets/js/html5shiv.js"></script>
    <script src="assets/js/respond.min.js"></script>
    <![endif]-->

    <!-- Favicons -->
    <link rel="fhir-logo" sizes="144x144" href="assets/ico/icon-fhir-144.png"/>
    <link rel="fhir-logo" sizes="114x114" href="assets/ico/icon-fhir-114.png"/>
    <link rel="fhir-logo" sizes="72x72" href="assets/ico/icon-fhir-72.png"/>
    <link rel="fhir-logo" href="assets/ico/icon-fhir-57.png"/>
    <link rel="shortcut icon" href="assets/ico/favicon.png"/>
  </head>
  <body onload="document.body.style.opacity='1'">

	  <script src="assets/js/prism.js"></script>
    <script type="text/javascript" src="assets/js/mermaid.js"></script>
    <script type="text/javascript" src="assets/js/mermaid-init.js"></script>
    <style type="text/css">h2{--heading-prefix:"15.101"}
    h3,h4,h5,h6{--heading-prefix:"15.101"}</style>
    <div id="segment-header" class="segment">  <!-- segment-header -->
      <div class="container">  <!-- container -->

        <!-- Placeholder for child template header declarations -->

            <!--
<div id="family-nav">
	<a id="logo" no-external="true" href="http://hl7.org/fhir"> <img
		alt="logo fhir" src="assets/images/fhir-logo-www.png" />
	</a>
</div>
-->


            <div id="family-nav">
                <a id="logo" no-external="true" href="searchform.html">
                    <img src="assets/images/search.png" alt="Search FHIR" />
                </a>
            </div>
            <div id="hl7-nav">
    <a id="logo" no-external="true" href="https://www.bag.admin.ch/bag/en/home.html">
        <img alt="visit the website" height="60" src="bag-logo.jpg" />
    </a>            
</div>

        <div id="ig-status">
          <p><span style="font-size:12pt;font-weight:bold">CH EPL (R5)</span>
            <br/>
            <span style="display:inline-block;">1.0.0-ballot - ballot



  <img alt="Switzerland flag" src="assets/images/che.svg" height="16" title="Switzerland"/>


            </span>
          </p>
        </div>
      </div> <!-- /container -->
    </div>  <!-- /segment-header -->

    <div id="segment-navbar" class="segment">  <!-- segment-navbar -->
      <div id="stripe"> </div>
      <div class="container">  <!-- container -->
        <!-- HEADER CONTENT -->

        <nav class="navbar navbar-inverse">
          <!--status-bar-->
          <div class="container">
            <button data-target=".navbar-inverse-collapse" class="navbar-toggle" data-toggle="collapse" type="button">
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
            </button>
            <a class="navbar-brand hidden" href="http://hl7.org/fhir/R5/index.html">FHIR</a>
            <div class="nav-collapse collapse navbar-inverse-collapse">
              <!-- menu.xml  -->

<ul xmlns="http://www.w3.org/1999/xhtml" class="nav navbar-nav">
  <li>
    <a href="index.html">Home</a>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Documentation
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="idmp.html">ISO IDMP</a>
      </li>
      <li>
        <a href="authorised-medicinal-product.html">Datasource</a>
      </li>
      <li>
        <a href="spezialitaetenliste.html">Spezialitätenliste</a>
      </li>
    </ul>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Examples
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="cuprior.html">Cuprior</a>
      </li>
      <li>
        <a href="entocort.html">Entocort</a>
      </li>
      <li>
        <a href="estalis.html">Estalis</a>
      </li>
      <li>
        <a href="keytruda.html">Keytruda</a>
      </li>
      <li>
        <a href="paxlovid.html">Paxlovid</a>
      </li>
      <li>
        <a href="triogen.html">Triogen</a>
      </li>
    </ul>
  </li>
  <li>
    <a href="profiles.html">Profiles</a>
  </li>
  <li>
    <a href="extensions.html">Extensions</a>
  </li>
  <li>
    <a href="terminology.html">Terminology</a>
  </li>
  <li>
    <a href="artifacts.html">Artifacts</a>
  </li>
</ul>
            </div>  <!-- /.nav-collapse -->
          </div>  <!-- /.container -->
        </nav>  <!-- /.navbar -->
      <!-- /HEADER CONTENT -->
      </div>  <!-- /container -->
    </div>  <!-- /segment-navbar -->
    <!--status-bar-->

    <div id="segment-breadcrumb" class="segment">  <!-- segment-breadcrumb -->
      <div class="container">  <!-- container -->
        <ul class="breadcrumb">
          <li><a href='toc.html'><b>Table of Contents</b></a></li><li><a href='artifacts.html'><b>Artifacts Summary</b></a></li><li><b>CUPRIOR Filmtabl 150 mg 72 Stk (Bundle)</b></li>

        </ul>
      </div>  <!-- /container -->
    </div>  <!-- /segment-breadcrumb -->

    <a name="top"> </a>
    <div id="segment-content" class="segment">  <!-- segment-content -->
      <div class="container">  <!-- container -->
        <div class="row">
          <div class="inner-wrapper">

<div class="col-12">
  <!--ReleaseHeader--><p id="publish-box">This page is part of the CH EPL (R5) (v1.0.0-ballot: <a data-no-external="true" href="https://confluence.hl7.org/display/HL7/HL7+Balloting" title="Draft Standard for Trial-Use">DSTU</a> 1 Ballot 1) based on <a data-no-external="true" href="http://hl7.org/fhir/R5">FHIR (HL7® FHIR® Standard) v5.0.0</a>. This is the current published version.  For a full list of available versions, see the <a data-no-external="true" href="http://fhir.ch/ig/ch-epl/history.html">Directory of published versions</a></p><!--EndReleaseHeader-->

  








<ul class="nav nav-tabs">

  <li class="active">
    <a href="#">Narrative Content</a>
  </li>



  
    <li>
      <a href="Bundle-08f553cb-1404-4972-bf14-2023a5f59955.xml.html">XML</a>
    </li>
  


  
    <li>
      <a href="Bundle-08f553cb-1404-4972-bf14-2023a5f59955.json.html">JSON</a>
    </li>
  




</ul>


  <a name="root"> </a>


  <h2 id="root">Example Bundle: CUPRIOR Filmtabl 150 mg 72 Stk (Bundle)</h2>




  <!-- insert intro if present -->
  



  <div><p class="res-header-id"><b>Generated Narrative: Bundle 08f553cb-1404-4972-bf14-2023a5f59955</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-bundle.html">IDMP Bundle</a></p></div><p>Bundle 08f553cb-1404-4972-bf14-2023a5f59955 of type collection</p><a name="http-//example.org/MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet"> </a><a name="MedicinalProductDefinition_Cuprior-150mg-Filmcoatedtablet"> </a><a name="hcMedicinalProductDefinition_Cuprior-150mg-Filmcoatedtablet"> </a><hr/><p>Entry 1 - fullUrl = http://example.org/MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet</p><p>Resource MedicinalProductDefinition:</p><blockquote><p class="res-header-id"><b>Generated Narrative: MedicinalProductDefinition Cuprior-150mg-Filmcoatedtablet</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/Cuprior-150mg-Filmcoatedtablet"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/Cuprior-150mg-Filmcoatedtablet"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/Cuprior-150mg-Filmcoatedtablet-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-medicinalproductdefinition.html">IDMP MedicinalProductDefinition</a></p></div><p><b>CH - SMC Authorized Dose Form</b>: <span title="Codes:{http://standardterms.edqm.eu 10221000}">Film-coated tablet</span></p><p><b>CH - EPL Full Limitation Text</b>: CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.</p><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID</code>/CH-7640109110007-6771901</p><p><b>domain</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/100000000004 100000000012}">Human</span></p><p><b>indication</b>: </p><div><p>Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.</p>
</div><p><b>legalStatusOfSupply</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply 756005022003}">Medicinal product subject to medical or veterinary prescription (B)</span></p><p><b>additionalMonitoringIndicator</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-additional-monitoring-indicator 756005001003}">No Warning</span></p><p><b>pediatricUseIndicator</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-pediatric-use-indicator 756005003001}">Authorised for the treatment in children</span></p><p><b>classification</b>: <span title="Codes:{http://www.whocc.no/atc L01EX13}">gilteritinib</span>, <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category 756005021001}">NA KAS art. 12 para. 5 TPLO</span>, <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode 756005004001}">Synthetic</span>, <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-product-type 756001003002}">Originator product</span></p><p><b>attachedDocument</b>: </p><ul><li><a href="DocumentReference-DocRef-FI-Cuprior.html">DocumentReference: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-AttachmentNumber#123456789-initial submission-Example-abc-123; status = current; type = Fachinformation; date = 2020-09-01 00:00:00+0000</a></li><li><a href="DocumentReference-DocRef-PI-Cuprior.html">DocumentReference: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-AttachmentNumber#123456789-initial submission-Example-abc-321; status = current; type = Patienteninformation; date = 2020-09-01 00:00:00+0000</a></li></ul><blockquote><p><b>name</b></p><p><b>productName</b>: Cuprior 150 mg, Filmtabletten</p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type SMC}">Zugelassener Arzneimittelname</span></p><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{urn:iso:std:iso:3166 CH}">Switzerland</span></td><td><span title="Codes:{urn:ietf:bcp:47 de-CH}">German (Switzerland)</span></td></tr></table></blockquote></blockquote><a name="http-//example.org/DocumentReference/DocRef-FI-Cuprior"> </a><a name="DocumentReference_DocRef-FI-Cuprior"> </a><a name="hcDocumentReference_DocRef-FI-Cuprior"> </a><hr/><p>Entry 2 - fullUrl = http://example.org/DocumentReference/DocRef-FI-Cuprior</p><p>Resource DocumentReference:</p><blockquote><p class="res-header-id"><b>Generated Narrative: DocumentReference DocRef-FI-Cuprior</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/DocRef-FI-Cuprior"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/DocRef-FI-Cuprior"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/DocRef-FI-Cuprior-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Language: de-CH</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-documentreference.html">CH IDMP DocumentReference</a></p></div><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-AttachmentNumber</code>/123456789-initial submission-Example-abc-123</p><p><b>status</b>: Current</p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type 756005007001}">Fachinformation</span></p><p><b>date</b>: 2020-09-01 00:00:00+0000</p><blockquote><p><b>content</b></p><h3>Attachments</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Url</b></td></tr><tr><td style="display: none">*</td><td><a href="https://swissmedicinfo.ch/showText.aspx?textType=FI&amp;lang=DE&amp;authNr=67719&amp;supportMultipleResults=1">https://swissmedicinfo.ch/showText.aspx?textType=FI&amp;lang=DE&amp;authNr=67719&amp;supportMultipleResults=1</a></td></tr></table></blockquote></blockquote><a name="http-//example.org/DocumentReference/DocRef-PI-Cuprior"> </a><a name="DocumentReference_DocRef-PI-Cuprior"> </a><a name="hcDocumentReference_DocRef-PI-Cuprior"> </a><hr/><p>Entry 3 - fullUrl = http://example.org/DocumentReference/DocRef-PI-Cuprior</p><p>Resource DocumentReference:</p><blockquote><p class="res-header-id"><b>Generated Narrative: DocumentReference DocRef-PI-Cuprior</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/DocRef-PI-Cuprior"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/DocRef-PI-Cuprior"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/DocRef-PI-Cuprior-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Language: de-CH</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-documentreference.html">CH IDMP DocumentReference</a></p></div><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-AttachmentNumber</code>/123456789-initial submission-Example-abc-321</p><p><b>status</b>: Current</p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type 756005007002}">Patienteninformation</span></p><p><b>date</b>: 2020-09-01 00:00:00+0000</p><blockquote><p><b>content</b></p><h3>Attachments</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Url</b></td></tr><tr><td style="display: none">*</td><td><a href="https://swissmedicinfo.ch/showText.aspx?textType=PI&amp;lang=DE&amp;authNr=67719&amp;supportMultipleResults=1">https://swissmedicinfo.ch/showText.aspx?textType=PI&amp;lang=DE&amp;authNr=67719&amp;supportMultipleResults=1</a></td></tr></table></blockquote></blockquote><a name="http-//example.org/RegulatedAuthorisation/MA-6771901"> </a><a name="RegulatedAuthorization_MA-6771901"> </a><a name="hcRegulatedAuthorization_MA-6771901"> </a><hr/><p>Entry 4 - fullUrl = http://example.org/RegulatedAuthorisation/MA-6771901</p><p>Resource RegulatedAuthorization:</p><blockquote><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization MA-6771901</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/MA-6771901"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/MA-6771901"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/MA-6771901-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-regulatedauthorization.html">IDMP RegulatedAuthorization</a></p></div><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MarketingAuthorisationNumber</code>/6771901</p><p><b>subject</b>: <a href="MedicinalProductDefinition-Cuprior-150mg-Filmcoatedtablet.html">MedicinalProductDefinition: extension = Film-coated tablet,CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7640109110007-6771901; domain = Human; indication = Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = gilteritinib,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type 756000002001}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{urn:iso:std:iso:3166 CH}">Switzerland</span></p><p><b>status</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status 756005023007}">valid</span></p><p><b>statusDate</b>: 2021-01-21</p><p><b>holder</b>: <a href="#hc08f553cb-1404-4972-bf14-2023a5f59955/MA-6771901/holder-Curatis-AG">Organization Curatis AG</a></p><p><b>regulator</b>: <a href="#hc08f553cb-1404-4972-bf14-2023a5f59955/MA-6771901/regulator-SMC">Organization SMC</a></p><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #holder-Curatis-AG</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/MA-6771901/holder-Curatis-AG"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/MA-6771901/holder-Curatis-AG"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/MA-6771901/holder-Curatis-AG-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-epl-organization.html">CH EPL Organization</a></p></div><p><b>identifier</b>: <a href="NamingSystem-LOC.html" title="Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS)">LOC Identifier</a>/100082791, <a href="NamingSystem-GLN.html" title="Identifier holding a number for GLN (Global Location Number)">GLN Identifier</a>/7640109110007</p><p><b>name</b>: Curatis AG</p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #regulator-SMC</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/MA-6771901/regulator-SMC"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/MA-6771901/regulator-SMC"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/MA-6771901/regulator-SMC-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-epl-organization.html">CH EPL Organization</a></p></div><p><b>identifier</b>: <a href="NamingSystem-LOC.html" title="Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS)">LOC Identifier</a>/100010911, <a href="NamingSystem-GLN.html" title="Identifier holding a number for GLN (Global Location Number)">GLN Identifier</a>/7601001398511</p><p><b>name</b>: SMC</p></blockquote></blockquote><a name="http-//example.org/PackagedProductDefinition/PMP-Cuprior-150mg-Filmcoatedtablet"> </a><a name="PackagedProductDefinition_PMP-Cuprior-150mg-Filmcoatedtablet"> </a><a name="hcPackagedProductDefinition_PMP-Cuprior-150mg-Filmcoatedtablet"> </a><hr/><p>Entry 5 - fullUrl = http://example.org/PackagedProductDefinition/PMP-Cuprior-150mg-Filmcoatedtablet</p><p>Resource PackagedProductDefinition:</p><blockquote><p class="res-header-id"><b>Generated Narrative: PackagedProductDefinition PMP-Cuprior-150mg-Filmcoatedtablet</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/PMP-Cuprior-150mg-Filmcoatedtablet"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/PMP-Cuprior-150mg-Filmcoatedtablet"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/PMP-Cuprior-150mg-Filmcoatedtablet-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-packagedproductdefinition.html">IDMP PackagedProductDefinition</a></p></div><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-PCID</code>/CH-7640109110007-6771901-001</p><p><b>packageFor</b>: <a href="MedicinalProductDefinition-Cuprior-150mg-Filmcoatedtablet.html">MedicinalProductDefinition: extension = Film-coated tablet,CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7640109110007-6771901; domain = Human; indication = Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = gilteritinib,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><p><b>containedItemQuantity</b>: 72 Tablet<span style="background: LightGoldenRodYellow"> (Details: EDQM - Standard Terms  code15054000 = 'Tablet')</span></p><p><b>description</b>: </p><div><p>CUPRIOR Filmtabl 150 mg 72 Stk</p>
</div><h3>LegalStatusOfSupplies</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply 756005022003}">Medicinal product subject to medical or veterinary prescription (B)</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>identifier</b>: <a href="NamingSystem-GTIN.html" title="GS1 defines trade items as products or services that are priced, ordered or invoiced at any point in the supply chain.">Global Trade Item Number</a>/7680677190018</p><p><b>type</b>: <span title="Codes:{http://standardterms.edqm.eu 30009000}">Box</span></p><p><b>quantity</b>: 1</p><h3>ShelfLifeStorages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Period[x]</b></td><td><b>SpecialPrecautionsForStorage</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://spor.ema.europa.eu/v1/lists/100000073343 100000073403}">Shelf life of the medicinal product as packaged for sale</span></td><td>No display for Duration  (value: 36; unit: month; system: http://unitsofmeasure.org; code: mo)</td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-special-precautions-for-storage 756005042009}">Do not store above  30°C</span></td></tr></table></blockquote><h3>Characteristics</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Value[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-other-characteristics-type 756000003001}">Package Size Type</span></td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-other-characteristics-packaged-item 756005041001}">Modal pack</span></td></tr></table></blockquote><a name="http-//example.org/RegulatedAuthorisation/MA-67719001"> </a><a name="RegulatedAuthorization_MA-67719001"> </a><a name="hcRegulatedAuthorization_MA-67719001"> </a><hr/><p>Entry 6 - fullUrl = http://example.org/RegulatedAuthorisation/MA-67719001</p><p>Resource RegulatedAuthorization:</p><blockquote><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization MA-67719001</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/MA-67719001"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/MA-67719001"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/MA-67719001-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-regulatedauthorization.html">IDMP RegulatedAuthorization</a></p></div><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MarketingAuthorisationNumber</code>/67719001</p><p><b>subject</b>: <a href="PackagedProductDefinition-PMP-Cuprior-150mg-Filmcoatedtablet.html">PackagedProductDefinition: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-PCID#CH-7640109110007-6771901-001; containedItemQuantity = 72 Tablet; description = CUPRIOR Filmtabl 150 mg 72 Stk</a></p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type 756000002001}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{urn:iso:std:iso:3166 CH}">Switzerland</span></p><p><b>status</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status 756005023007}">valid</span></p><p><b>statusDate</b>: 2021-01-21</p><p><b>holder</b>: <a href="#hc08f553cb-1404-4972-bf14-2023a5f59955/MA-67719001/holder-Curatis-AG">Organization Curatis AG</a></p><p><b>regulator</b>: <a href="#hc08f553cb-1404-4972-bf14-2023a5f59955/MA-67719001/regulator-SMC">Organization SMC</a></p><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #holder-Curatis-AG</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/MA-67719001/holder-Curatis-AG"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/MA-67719001/holder-Curatis-AG"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/MA-67719001/holder-Curatis-AG-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-epl-organization.html">CH EPL Organization</a></p></div><p><b>identifier</b>: <a href="NamingSystem-LOC.html" title="Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS)">LOC Identifier</a>/100082791, <a href="NamingSystem-GLN.html" title="Identifier holding a number for GLN (Global Location Number)">GLN Identifier</a>/7640109110007</p><p><b>name</b>: Curatis AG</p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #regulator-SMC</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/MA-67719001/regulator-SMC"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/MA-67719001/regulator-SMC"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/MA-67719001/regulator-SMC-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-epl-organization.html">CH EPL Organization</a></p></div><p><b>identifier</b>: <a href="NamingSystem-LOC.html" title="Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS)">LOC Identifier</a>/100010911, <a href="NamingSystem-GLN.html" title="Identifier holding a number for GLN (Global Location Number)">GLN Identifier</a>/7601001398511</p><p><b>name</b>: SMC</p></blockquote></blockquote><a name="http-//example.org/RegulatedAuthorisation/FOPH-21208"> </a><a name="RegulatedAuthorization_FOPH-21208"> </a><a name="hcRegulatedAuthorization_FOPH-21208"> </a><hr/><p>Entry 7 - fullUrl = http://example.org/RegulatedAuthorisation/FOPH-21208</p><p>Resource RegulatedAuthorization:</p><blockquote><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization FOPH-21208</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/FOPH-21208"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/FOPH-21208"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/FOPH-21208-en-US"> </a><blockquote><p><b>CH - EPL Reimbursement SL</b></p><ul><li>FOPHDossierNumber: <a href="NamingSystem-Dossier.html" title="Identifier holding the Dossier number of FOPH">FOPH Dossier Number</a>/21208</li><li>status: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-reimbursement-status 756001021001}">Reimbursed</span></li><li>statusDate: 2021-08-01</li><li>listingStatus: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-listing-status 756001002001}">Listed</span></li><li>listingPeriod: 2021-08-01 --&gt; (ongoing)</li><li>firstListingDate: 2021-08-01</li><li>costShare: 10</li><li>gamme: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-gamme 756002004001}">Oral</span></li></ul></blockquote><blockquote><p><b>CH - EPL Product Price</b></p><ul><li>value: <span title="Swiss Franc">CHF3,022.10</span> (CHF)</li><li>type: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type 756002005002}">Ex-factory price</span></li><li>changeType: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change 756002006007}">Price mutation after triennal review of pharmaceuticals</span></li><li>changeDate: 2024-01-01</li></ul></blockquote><blockquote><p><b>CH - EPL Product Price</b></p><ul><li>value: <span title="Swiss Franc">CHF3,347.10</span> (CHF)</li><li>type: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type 756002005001}">Retail price</span></li><li>changeType: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change 756002006005}">VAT-change</span></li><li>changeDate: 2024-01-01</li></ul></blockquote><p><b>subject</b>: <a href="PackagedProductDefinition-PMP-Cuprior-150mg-Filmcoatedtablet.html">PackagedProductDefinition: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-PCID#CH-7640109110007-6771901-001; containedItemQuantity = 72 Tablet; description = CUPRIOR Filmtabl 150 mg 72 Stk</a></p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type 756000002003}">Reimbursement SL</span></p><h3>Indications</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Extension</b></td><td><b>Reference</b></td></tr><tr><td style="display: none">*</td><td/><td><a href="ClinicalUseDefinition-IND-10061091.html">ClinicalUseDefinition: type = indication</a></td></tr></table><p><b>holder</b>: <a href="#hc08f553cb-1404-4972-bf14-2023a5f59955/FOPH-21208/holder-Curatis-AG">Organization Curatis AG</a></p><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #holder-Curatis-AG</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/FOPH-21208/holder-Curatis-AG"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/FOPH-21208/holder-Curatis-AG"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/FOPH-21208/holder-Curatis-AG-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-epl-organization.html">CH EPL Organization</a></p></div><p><b>identifier</b>: <a href="NamingSystem-LOC.html" title="Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS)">LOC Identifier</a>/100082791, <a href="NamingSystem-GLN.html" title="Identifier holding a number for GLN (Global Location Number)">GLN Identifier</a>/7640109110007</p><p><b>name</b>: Curatis AG</p></blockquote></blockquote><a name="http-//example.org/ManufacturedItemDefinition/MI-Trientinum-150mg-Filmcoatedtablet"> </a><a name="ManufacturedItemDefinition_MI-Trientinum-150mg-Filmcoatedtablet"> </a><a name="hcManufacturedItemDefinition_MI-Trientinum-150mg-Filmcoatedtablet"> </a><hr/><p>Entry 8 - fullUrl = http://example.org/ManufacturedItemDefinition/MI-Trientinum-150mg-Filmcoatedtablet</p><p>Resource ManufacturedItemDefinition:</p><blockquote><p class="res-header-id"><b>Generated Narrative: ManufacturedItemDefinition MI-Trientinum-150mg-Filmcoatedtablet</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/MI-Trientinum-150mg-Filmcoatedtablet"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/MI-Trientinum-150mg-Filmcoatedtablet"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/MI-Trientinum-150mg-Filmcoatedtablet-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-manufactureditemdefinition.html">CH IDMP ManufacturedItemDefinition</a></p></div><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title="Codes:{http://standardterms.edqm.eu 10221000}">Film-coated tablet</span></p><p><b>unitOfPresentation</b>: <span title="Codes:{http://standardterms.edqm.eu 15054000}">Tablet</span></p></blockquote><a name="http-//example.org/AdministrableProductDefinition/PhP-Trientinum-150mg-Filmcoatedtablet"> </a><a name="AdministrableProductDefinition_PhP-Trientinum-150mg-Filmcoatedtablet"> </a><a name="hcAdministrableProductDefinition_PhP-Trientinum-150mg-Filmcoatedtablet"> </a><hr/><p>Entry 9 - fullUrl = http://example.org/AdministrableProductDefinition/PhP-Trientinum-150mg-Filmcoatedtablet</p><p>Resource AdministrableProductDefinition:</p><blockquote><p class="res-header-id"><b>Generated Narrative: AdministrableProductDefinition PhP-Trientinum-150mg-Filmcoatedtablet</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/PhP-Trientinum-150mg-Filmcoatedtablet"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/PhP-Trientinum-150mg-Filmcoatedtablet"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/PhP-Trientinum-150mg-Filmcoatedtablet-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-administrableproductdefinition.html">CH IDMP AdministrableProductDefinition</a></p></div><p><b>status</b>: Active</p><p><b>formOf</b>: <a href="MedicinalProductDefinition-Cuprior-150mg-Filmcoatedtablet.html">MedicinalProductDefinition: extension = Film-coated tablet,CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7640109110007-6771901; domain = Human; indication = Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = gilteritinib,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><p><b>administrableDoseForm</b>: <span title="Codes:{http://standardterms.edqm.eu 10221000}">Film-coated tablet</span></p><p><b>unitOfPresentation</b>: <span title="Codes:{http://standardterms.edqm.eu 15054000}">Tablet</span></p><h3>RouteOfAdministrations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://standardterms.edqm.eu 20053000}">Oral use</span></td></tr></table></blockquote><a name="http-//example.org/Ingredient/Trientinum150"> </a><a name="Ingredient_Trientinum150"> </a><a name="hcIngredient_Trientinum150"> </a><hr/><p>Entry 10 - fullUrl = http://example.org/Ingredient/Trientinum150</p><p>Resource Ingredient:</p><blockquote><p class="res-header-id"><b>Generated Narrative: Ingredient Trientinum150</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/Trientinum150"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/Trientinum150"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/Trientinum150-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-ingredient.html">IDMP Ingredient</a></p></div><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="AdministrableProductDefinition-PhP-Trientinum-150mg-Filmcoatedtablet.html">AdministrableProductDefinition: status = active; administrableDoseForm = Film-coated tablet; unitOfPresentation = Tablet</a></li><li><a href="ManufacturedItemDefinition-MI-Trientinum-150mg-Filmcoatedtablet.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Film-coated tablet; unitOfPresentation = Tablet</a></li></ul><p><b>role</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-ingredient-role 756005051001}">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-substance SJ76Y07H5F}">Trientine</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td></tr><tr><td style="display: none">*</td><td>150 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM  codemg = 'mg')</span>/1 Tablet<span style="background: LightGoldenRodYellow"> (Details: EDQM - Standard Terms  code15054000 = 'Tablet')</span></td></tr></table></blockquote></blockquote><a name="http-//example.org/ClinicalUseDefinition/IND-10061091"> </a><a name="ClinicalUseDefinition_IND-10061091"> </a><a name="hcClinicalUseDefinition_IND-10061091"> </a><hr/><p>Entry 11 - fullUrl = http://example.org/ClinicalUseDefinition/IND-10061091</p><p>Resource ClinicalUseDefinition:</p><blockquote><p class="res-header-id"><b>Generated Narrative: ClinicalUseDefinition IND-10061091</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/IND-10061091"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/IND-10061091"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/IND-10061091-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-clinicalusedefinition-indication.html">CH IDMP ClinicalUseDefinition Indication</a></p></div><p><b>type</b>: Indication</p><p><b>subject</b>: <a href="MedicinalProductDefinition-Cuprior-150mg-Filmcoatedtablet.html">MedicinalProductDefinition: extension = Film-coated tablet,CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7640109110007-6771901; domain = Human; indication = Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = gilteritinib,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><blockquote><p><b>indication</b></p><h3>DiseaseSymptomProcedures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://www.meddra.org 10061091}">Wilson's disease</span></td></tr></table><h3>IntendedEffects</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://spor.ema.europa.eu/v1/lists/200000003186 200000003194}">therapeutic</span></td></tr></table></blockquote></blockquote><a name="http-//example.org/ClinicalUseDefinition/LIM-79886009"> </a><a name="ClinicalUseDefinition_LIM-79886009"> </a><a name="hcClinicalUseDefinition_LIM-79886009"> </a><hr/><p>Entry 12 - fullUrl = http://example.org/ClinicalUseDefinition/LIM-79886009</p><p>Resource ClinicalUseDefinition:</p><blockquote><p class="res-header-id"><b>Generated Narrative: ClinicalUseDefinition LIM-79886009</b></p><a name="08f553cb-1404-4972-bf14-2023a5f59955/LIM-79886009"> </a><a name="hc08f553cb-1404-4972-bf14-2023a5f59955/LIM-79886009"> </a><a name="08f553cb-1404-4972-bf14-2023a5f59955/LIM-79886009-en-US"> </a><p><b>type</b>: Indication</p><blockquote><p><b>indication</b></p><h3>DiseaseSymptomProcedures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://snomed.info/sct 79886009}">Disorder of copper metabolism</span></td></tr></table><h3>IntendedEffects</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://spor.ema.europa.eu/v1/lists/200000003186 200000003194}">therapeutic</span></td></tr></table></blockquote></blockquote></div>

  

  <!-- insert notes if present -->
  



</div>
        </div>  <!-- /inner-wrapper -->
      </div>  <!-- /row -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-content -->

  <script type="text/javascript" src="assets/js/jquery.js"> </script>     <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
  <script type="text/javascript" src="assets/js/jquery-ui.min.js"> </script>

  <script type="text/javascript" src="assets/js/window-hash.js"> </script>
  <a name="bottom"> </a>
  <div id="segment-footer" igtool="footer" class="segment">  <!-- segment-footer -->
    <div class="container">  <!-- container -->

      <div class="inner-wrapper">
        <p>
          IG &#169; 2023+ <a style="color:var(--footer-hyperlink-text-color)" href="https://www.bag.admin.ch/bag/en/home/das-bag/kontakt-standort.html">Federal Office of Public Health FOPH</a>.  Package ch.fhir.ig.ch-epl#1.0.0-ballot based on <a style="color: var(--footer-hyperlink-text-color)" href="http://hl7.org/fhir/R5/">FHIR 5.0.0</a>. Generated <span title="Thu, May 22, 2025 14:35+0000">2025-05-22</span>
          <br/>
          <span style="color: var(--footer-highlight-text-color)">
                      Links: <a style="color: var(--footer-hyperlink-text-color)" href="toc.html">Table of Contents</a> |
                 <a style="color: var(--footer-hyperlink-text-color)" href="qa.html">QA Report</a>
                 
                

| <a style="color: #81BEF7" target="_blank" href="https://docs.google.com/forms/d/e/1FAIpQLSd1mLI82dQJ5LFoMXSXywgaCqtHnaADtuHQkMJoLwONsPg9cw/viewform?usp=dialog&amp;entry%2E1353807103=ch.fhir.ig.ch-epl%231.0.0-ballot%20/Bundle-08f553cb-1404-4972-bf14-2023a5f59955.html&amp;entry%2E247644557=CUPRIOR%20Filmtabl%20150%20mg%2072%20Stk%20(Bundle)">Propose a change</a>




          </span>
        </p>
      </div>  <!-- /inner-wrapper -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-footer -->
  
  <div id="segment-post-footer" class="segment hidden">  <!-- segment-post-footer -->
    <div class="container">  <!-- container -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-post-footer -->

  <!-- JS and analytics only. -->
  <!-- Bootstrap core JavaScript
  ================================================== -->
  <!-- Placed at the end of the document so the pages load faster -->
  <script type="text/javascript" src="assets/js/bootstrap.min.js"> </script>
  <script type="text/javascript" src="assets/js/respond.min.js"> </script>
  <script type="text/javascript" src="assets/js/anchor.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard-btn.js"> </script>
  <script type="text/javascript" src="assets/js/anchor-hover.js"> </script>
  <!-- Analytics Below
  ================================================== -->
  </body>
</html>

